// App-Quantinova.ai

: Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys

Researchers

Presenter

  • Olaf Penack

Principal Investigators

  • Christian Koenecke

  • Emmanuelle Polge

  • Victoria Potter

  • Ibrahim Yakoub-Agha

  • Nathalie Fegueux

  • Michael Daskalakis

  • Matthew P. Collin

  • Peter Dreger

  • Nicolaus Kroger

  • Urs Schanz

  • Adrian Bloor

  • Arnold Ganser

  • Caroline Besley

  • Gerald Wulf

  • Urban Novak

  • Ivan Moiseev

  • Helene Schoemans

  • Grzegorz W Basak

  • Christian Chabannon

  • Anna Sureda

  • Bertram Glass

  • Zinaida Peric

Medical Centers

  • EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR , Sorbonne University, Paris, France

  • Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland

  • Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany

  • ALWP of the EBMT Paris office, Saint Antoine Hospital; INSERM UMR , Sorbonne University, Paris, France

  • Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany

  • RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia

  • The Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

  • Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France

  • Bristol Royal Hospital for Children, Dept. of Paediatric Oncology/BMT, Bristol, United Kingdom

  • Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France

  • Institute of Immunology, Hannover Medical School, Hannover, Germany

  • Centre Hospitalier Universitaire de Lille LIRIC, INSERM U, Université de Lille, Lille, France

  • BSBMTCT, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Department of Hematology, Transplantation, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland

  • Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany

  • Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany

  • Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany

  • University Hospital Centre Zagreb, Zagreb, CROATIA

  • Adult HSCT unit, Newcastle, United Kingdom, Newcastle, United Kingdom

  • University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany

  • Department of Hematology, University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • Department of Hematology and Central Hematology Laboratory, University Hospital, Bern, Switzerland

  • Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

Locations

  • France

  • Russia

  • Croatia

  • Switzerland

  • United Kingdom

  • Germany

  • Poland

  • Belgium

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • B cell lymphomas

  • Nephrotoxicity

  • Lymphomas

Biomarkers

  • Cluster of Differentiation 19

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved